Both the upstream and downstream regulators of KHDC4 and TRAF2 consistently indicate that, apart from participating in tumor malignancy, the molecules centered around the KHDC4-TRAF2 axis can be further utilized as a PCa prognosis signature, as illustrated in Figure 6. The gene discussed is KHDC4; the disease is neoplasm.